Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06799390 · ClinicalTrials.gov registry record · NA
Auricular VNS Following Intracerebral Hemorrhage
A NA study of Intracerebral Hemorrhage, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06799390: Recruiting NA study of Intracerebral Hemorrhage, sponsored by Washington University School of Medicine.
NCT06799390 is a NA study of Intracerebral Hemorrhage that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 80 participants, below the 1,103-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06799390, a NA study of Intracerebral Hemorrhage, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following intracerebral hemorrhage.
Primary Outcome
Blood samples collected on days 1, 4, 7, 10, and 14 (Day 1 serves as baseline, prior to first treatment). Inflammatory markers will be reported in pg/mL.
Conditions Studied
Interventions
- DEVICE Auricular Vagus Nerve Stimulation
- DEVICE Sham Auricular Vagus nerve Stimulation
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-04-06 |
| Est. Completion | 2032-02-09 |
| Phase | NA |
What NCT06799390 shows while recruiting
NCT06799390 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,103-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 2 interventions - of which Auricular Vagus Nerve Stimulation is the first listed.
NCT06799390 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06799390 about?
NCT06799390 is a clinical study titled "Auricular VNS Following Intracerebral Hemorrhage". This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following intracerebral hemorrhage.
What is the current status of trial NCT06799390?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-04-06. Estimated completion is 2032-02-09.
What conditions does trial NCT06799390 study?
This clinical trial studies the following conditions: Intracerebral Hemorrhage.
What interventions are being tested in trial NCT06799390?
The interventions under investigation include: Auricular Vagus Nerve Stimulation (DEVICE), Sham Auricular Vagus nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT06799390?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06799390 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracerebral Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06799390's enrollment target sits among peer trials
80 24th of 31 higher than 8 of 31 other Intracerebral Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracerebral Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating a Prototype CT Scan for ICH Evacuation
RECRUITING · NA
-
Short-term And Longer-term Cognitive Impact Of Neurochecks
RECRUITING · NA
-
Implementation of Neuro Lung Protective Ventilation
ACTIVE NOT RECRUITING · NA
-
Stroke and CPAP Outcome Study 3
COMPLETED · NA
-
Hemodynamic ABI Monitor
RECRUITING
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI